Paper Details

  1. Home
  2. Paper Details

Optimizing current and emerging therapies in multiple myeloma: a guide for the hematologist.

Author: BowmanAlex S, LentzschSuzanne, RazaShahzad, RosenbaumEvan, SafyanRachael A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review outlines the current therapeutic approach to the management of multiple myeloma (MM). It highlights the advancements in treatment options, including proteasome inhibitors and immunomodulatory drugs, and emphasizes the importance of risk stratification, management of comorbidities, and treatment side effects.
Paper Details　
Original Abstract of the Article :
Multiple myeloma (MM) is the second most common hematologic malignancy. The diagnosis of MM requires ⩾10% clonal plasma cells in the bone marrow or biopsy-proven plasmacytoma, plus evidence of end-organ damage (hypercalcemia, renal failure, anemia, and lytic bone lesions). The definition of MM has r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298389/

データ提供：米国国立医学図書館（NLM）

Optimizing Therapies for Multiple Myeloma: A Comprehensive Guide

The world of [hematology] is a complex and dynamic field, and treating [multiple myeloma] requires a comprehensive and evolving approach. This study, like a skilled navigator charting a course through the desert of cancer treatment, provides a guide for hematologists on optimizing therapies for multiple myeloma.

Novel Therapies Offer New Hope for Multiple Myeloma

The researchers highlight the significant advances in multiple myeloma treatment, including the development of novel drugs like [carfilzomib], [ixazomib], [pomalidomide], and [panobinostat]. This progress is like discovering a hidden oasis in the desert, offering hope and a potential cure for this challenging disease.

A Multi-Layered Approach to Treatment

This study emphasizes the importance of a multi-layered approach to multiple myeloma treatment, considering factors such as risk stratification, comorbidities, and treatment side effects. It's a reminder that the journey through the desert of cancer treatment requires careful planning, adaptability, and a commitment to holistic patient care.

Dr.Camel's Conclusion

This comprehensive review offers a roadmap for hematologists treating multiple myeloma. It highlights the exciting progress made in this field, emphasizing the importance of individualized treatment plans and a collaborative approach to care. It's a testament to the ongoing efforts of researchers and clinicians to find innovative solutions for those facing the challenges of cancer.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-03-18
Further Info :

Pubmed ID

28203342

DOI: Digital Object Identifier

PMC5298389

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.